Characteristics of patients with erosive and nonerosive GERD in high-Helicobacter-pylori prevalence region

被引:27
作者
Jonaitis, LV
Kiudelis, G
Kupcinskas, L
机构
[1] Kaunas Univ Med, Lithuanian Helicobacter Policy Study Grp, LT-3000 Kaunas, Lithuania
[2] Kaunas Univ Med, Dept Gastroenterol, Kaunas, Lithuania
关键词
gastroesophageal reflux disease (GERD); Helicobacter pylori; nonerosive gastroesophageal reflux disease (NERD);
D O I
10.1111/j.1442-2050.2004.00412.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
It is still not known whether there are differences between erosive and nonerosive GERD. The aim of the present study is to evaluate the prevalence of Helicobacter pylori (HP) infection, and other differences between erosive and nonerosive gastroesophageal reflux disease (NERD) patients. One-hundred and four consecutive GERD patients (mean age: 41.6 +/- 12.3 years) were interviewed, endoscoped and tested for HP. Erosive GERD was defined according to the Los Angeles classification. Patients who had no erosions in the esophagus but complained of heartburn or/and acid regurgitation at least twice a week and for whom these symptoms had a negative impact on daily activities were considered to be NERD patients. Erosive GERD was identified in 53 (51%) patients (mean age: 41.0 +/- 12.7 years) and NERD in 51 (49.0%) patients (mean age: 42.2 +/- 11.9 years). HP infection was found in 32 (60.4%) erosive GERD patients, and 41 (80.4%) NERD patients, P < 0.05. Multivariate analysis revealed that there were two statistically significant prediction factors for NERD: female sex with odds ratio (OR) of 6.34 (95% CI: 2.41-16.64; P = 0.0002) and HP infection with odds ratio (OR) of 3.28 (95% CI: 1.26-8.58; P = 0.015). The presence of HP and female sex are found to be statistically significant predictors of NERD.
引用
收藏
页码:223 / 227
页数:5
相关论文
共 40 条
[1]
Arents NLA, 2001, AM J GASTROENTEROL, V96, P2603, DOI 10.1111/j.1572-0241.2001.04104.x
[2]
Armstrong D, 1999, YALE J BIOL MED, V72, P93
[3]
BALDI F, 1998, DIGEST DIS SCI, V12, P1890
[4]
Bielanski W, 1999, J PHYSIOL PHARMACOL, V50, P723
[5]
Chow WH, 1998, CANCER RES, V58, P588
[6]
An evidence-based appraisal of reflux disease management - the Genval workshop report [J].
Dent, J ;
Brun, J ;
Fendrick, AM ;
Fennerty, MB ;
Janssens, J ;
Kahrilas, PJ ;
Lauritsen, K ;
Reynolds, JC ;
Shaw, M ;
Talley, NJ .
GUT, 1999, 44 :S1-S16
[7]
Classification and grading of gastritis - The updated Sydney System [J].
Dixon, MF ;
Genta, RM ;
Yardley, JH ;
Correa, P ;
Batts, KP ;
Dahms, BB ;
Filipe, MI ;
Haggitt, RC ;
Haot, J ;
Hui, PK ;
Lechago, J ;
Lewin, K ;
Offerhaus, JA ;
Price, AB ;
Riddell, RH ;
Sipponen, P ;
Solcia, E ;
Watanabe, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) :1161-1181
[8]
Opposing time trends of peptic ulcer and reflux disease [J].
El-Serag, HB ;
Sonnenberg, A .
GUT, 1998, 43 (03) :327-333
[9]
Associations between different forms of gastro-oesophageal reflux disease [J].
ElSerag, HB ;
Sonnenberg, A .
GUT, 1997, 41 (05) :594-599
[10]
Fallone CA, 2000, AM J GASTROENTEROL, V95, P914, DOI 10.1111/j.1572-0241.2000.01929.x